Stay updated on Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-05-01T04:36:13.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of the study title 'Phase Ib/II Study of Neoadjuvant Pembrolizumab With Gemcitabine-Cisplatin' and the revision number has been updated from v2.14.4 to v2.15.0. Additionally, the collaborators have been specified as Hoosier Cancer Research Network and Merck Sharp & Dohme LLC.
    Difference
    48%
    Check dated 2025-04-16T14:35:33.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 18, 2025.
    Difference
    0.2%
    Check dated 2025-04-09T09:24:14.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version (v2.14.3) and a new last update date of March 25, 2025, replacing the previous estimated dates and version. This indicates a significant update to the content.
    Difference
    0.2%
    Check dated 2025-04-01T23:26:50.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The webpage has been updated to include new results and timelines for a clinical study involving pembrolizumab, including specific metrics for safety, relapse-free survival, and overall survival. Key dates for results reporting have also been added.
    Difference
    9%
    Check dated 2025-03-25T13:59:10.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.8%
    Check dated 2025-02-24T21:11:06.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page.